(7429.31052017.113000204) COMM-NM_2790 (Q2318649): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed an Item)
Property / contained in NUTS
 
Property / contained in NUTS: Province of Florence / rank
 
Normal rank

Revision as of 02:26, 17 July 2020

Project in Italy financed by DG Regio
Language Label Description Also known as
English
(7429.31052017.113000204) COMM-NM_2790
Project in Italy financed by DG Regio

    Statements

    0 references
    42,640.24 Euro
    0 references
    170,560.96 Euro
    0 references
    25.0 percent
    0 references
    25 September 2017
    0 references
    25 March 2019
    0 references
    13 September 2019
    0 references
    CNR - CONSIGLIO NAZIONALE DELLE RICERCHE - ISTITUTO DI SCIENZA E TECNOLOGIE DELL'INFORMAZIONE "A.FAEDO" - PISA
    0 references
    0 references

    43°46'11.53"N, 11°15'20.09"E
    0 references
    L?IDEA ALLA BASE DEL PROGETTO ? QUELLA DI SPERIMENTARE UNA NUOVA TECNOLOGIA NELL?AMBITO DELL?IMAGING MOLECOLARE (IM), CHE CI POSSA PERMETTERE DI CREARE INNOVAZIONE SIA IN CAMPO SCIENTIFICO CHE INDUSTRIALE IMPLEMENTANDO I RISULTATI E LE RICADUTE SOCIOSANITARIE ED ECONOMICHE IN QUESTA BRANCA DELLA MEDICINA.L?OBIETTIVO ? QUELLO DI PROGETTARE E VALIDARE UNA PIATTAFORMA DIAGNOSTICA CHE INTEGRI IN UNA SOLA MACCHINA SENSORI DI MEDICINA NUCLEARE (PET - TOMOGRAFIA AD EMISSIONE DI POSITRONI OPPURE SPECT ? TOMOGRAFIA COMPUTERIZZATA CON EMISSIONE DI SINGOLI FOTONI) CON LA TECNOLOGIA CBCT (CONE BEAM COMPUTED TOMOGRAPHY) AL FINE DI CREARE UN IBRIDO CON ELEVATA PERFORMANCE DIAGNOSTICA MA CON ULTERIORI VANTAGGI COSTITUITI DALLA MANEGGEVOLEZZA E TRASPORTABILIT? DATE LE RIDOTTE DIMENSIONI NONCH? DALL?ESTREMA COMPATTEZZA E DUTTILIT?. TALE TECNOLOGIA DI IMAGING IBRIDO (PET/CBCT E SPECT/CBCT) SAR? NEI NOSTRI INTENTI DEDICATA IN PARTICOLAR MODO ALLO STUDIO DIAGNOSTICO DELLE PATOLOGIE NEURO-DEGENERATIVE E DE (Italian)
    0 references
    THE IDEA BEHIND THE PROJECT? TO TEST A NEW TECHNOLOGY IN MOLECULAR IMAGING (IM), WHICH WOULD ENABLE US TO CREATE BOTH SCIENTIFIC AND INDUSTRIAL INNOVATION BY IMPLEMENTING THE RESULTS AND THE SOCIAL AND HEALTH AND ECONOMIC IMPACTS IN THIS MEDICINA.L? OBJECTIVE? DESIGN AND VALIDATE A DIAGNOSTIC PLATFORM INTEGRATING INTO ONE MACHINE NUCLEAR MEDICINE SENSOR (PET — POSITRON EMISSION TOMOGRAPHY OR SPECT? COMPUTED TOMOGRAPHY WITH INDIVIDUAL PHOTON EMISSIONS) WITH THE CBT-TECHNOLOGY (CONE BEAM COMPUTED AND TOMOGRAPHY) TECHNOLOGY IN ORDER TO CREATE A HYBRID WITH A HIGH DIAGNOSTIC PERFORMANCE BUT WITH ADDITIONAL BENEFITS OF THE MANAGEABILITY AND TRANSITICISITILIT? GIVEN THE SMALL SIZE OF THE PRODUCT? FROM THE EXTREME COMPACT AND DURWEN?. THIS HYBRID IMAGING TECHNOLOGY (PET/CPC AND SPECTC/CBCT) SAR? OUR AIMS IN PARTICULAR FOR THE DIAGNOSTIC STUDY ON NEURO-DEGENERATIVE DISEASES AND DE (English)
    0 references

    Identifiers